Plenary Session

387 Folgen

1. QuANTUM - Quizartinib Front Line - Ethics of Global Trials

   Vom: 15.6.2022
2. 4.67 Teclistimab for R/R Multiple Myeloma

   Vom: 9.6.2022
3. 4.66 PD1 Ab for MSI H Stage II/ III Rectal Cancer; A 100% CR rate??

   Vom: 8.6.2022
4. 4.65 DESTINY BREAST 04 - A complex trial to deconstruct

   Vom: 7.6.2022
5. 4.64 - DETERMINATION - Should we still use transplant Myeloma?

   Vom: 6.6.2022
6. 4.63 - ASCO22 - DYNAMIC - Can CT DNA Allow us to Give Less Chemo in Stage II Colon Cancer

   Vom: 5.6.2022
7. 4.62 - SHINE - Ibrutinib BR vs BR; Limitations to the trial

   Vom: 4.6.2022
8. 4.61 - How CDC's Vaccine Safety Missed Cases Of Myocarditis

   Vom: 27.5.2022
9. 4.60 - NEW JCO paper - AML, EFS, CR, CRi, and Surrogate validation - FDA & Methods

   Vom: 21.5.2022
10. 4.59 - How to be a better reader of case control studies

    Vom: 17.5.2022
11. 4.58 - Myeloma is a broken field - New BLOOD Paper!

    Vom: 14.5.2022
12. 4.57 - COVID19 and the Failures of Public Health w/ Leslie Bienen

    Vom: 6.5.2022
13. 4.56 - Fifth Installment of the brilliant Zeb Jamrozik

    Vom: 4.5.2022
14. 4.55 - Compilation Of Recent Covid Monologues

    Vom: 1.5.2022
15. 4.54 - Eric Collisson Professor, GI Oncologist, Physician Scientist

    Vom: 30.4.2022
16. 4.53 John Ioannidis lectures the VKPrasad Lab about COVID19

    Vom: 27.4.2022
17. 4.52 Vinay Prasad Gives a Lecture on COVID19 to a General Audience

    Vom: 24.4.2022
18. 4.51 - Vinay Prasad is Interviewed by Kristina Jenei About Academic Medicine

    Vom: 22.4.2022
19. 4.50 - Ivosidenib & Aza vs Aza, the AGILE, 6 huge problems; Journal club

    Vom: 21.4.2022
20. 4.49 - Malignant Book Club Part 3 Audio

    Vom: 15.4.2022